BJ
TEVA icon

BlackRock Japan’s Teva Pharmaceuticals TEVA Stock Holding History

BlackRock Japan’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$47M Buy
+1,297,628
New +$51.8M 0.16% 151
2016
Q3 		– Sell
-9,760
Closed -$490K – 1415
2016
Q2 		$490K Sell
9,760
-1,637
-14% -$87.1K ﹤0.01% 723
2016
Q1 		$610K Sell
11,397
-307,148
-96% -$18M ﹤0.01% 735
2015
Q4 		$20.9M Buy
318,545
+26,569
+9% +$1.64M 0.08% 286
2015
Q3 		$16.5M Buy
291,976
+48,310
+20% +$3.13M 0.07% 324
2015
Q2 		$14.4M Sell
243,666
-109,690
-31% -$6.77M 0.06% 387
2015
Q1 		$22M Buy
353,356
+22,380
+7% +$1.3M 0.09% 264
2014
Q4 		$19M Buy
330,976
+7,585
+2% +$423K 0.07% 308
2014
Q3 		$17.4M Buy
323,391
+11,944
+4% +$633K 0.08% 293
2014
Q2 		$16.3M Buy
311,447
+58,494
+23% +$2.99M 0.07% 298
2014
Q1 		$13.4M Buy
252,953
+235,753
+1,371% +$10.9M 0.06% 372
2013
Q4 		$689K Buy
17,200
+7,000
+69% +$276K ﹤0.01% 742
2013
Q3 		$385K Buy
10,200
+2,500
+32% +$97.5K ﹤0.01% 780
2013
Q2 		$302K Buy
+7,700
New +$300K ﹤0.01% 798

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

BlackRock Japan's TEVA Position: Q4 2016 in Review

BlackRock Japan opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2016: 1,297,628 shares worth $47M. The stake represents 0.16% of the portfolio and ranks #151 among its holdings. This is a return to the name: BlackRock Japan previously reported a position in TEVA as recently as Q2 2016.

BlackRock Japan first reported a position in TEVA in Q2 2013 and has held it in 14 quarters since. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • BlackRock Japan held 1,297,628 shares of Teva Pharmaceuticals worth $47M as of Q4 2016.
  • Teva Pharmaceuticals was a new BlackRock Japan position in Q4 2016.
  • Teva Pharmaceuticals made up 0.16% of BlackRock Japan's portfolio in Q4 2016, its #151 holding.
  • BlackRock Japan first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • 739 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.